Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Lilly to launch its obesity drug in Denmark, Novo Nordisk's home market
Lilly to launch its obesity drug in Denmark, Novo Nordisk's home market
Lilly to launch its obesity drug in Denmark, Novo Nordisk's home market
Submitted by
admin
on October 24, 2024 - 9:53am
Source:
Reuters
News Tags:
Eli Lilly
Mounjaro
Novo Nordisk
Denmark
obesity
Headline:
Lilly to launch its obesity drug in Denmark, Novo Nordisk's home market
snippet:
Lilly's Mounjaro to cost 2,200 Danish crowns per month
Wegovy's price ranges from 1,313 to 2,353 crowns per month
Denmark's public health system does not reimburse weight-loss drugs
Do Not Allow Advertisers to Use My Personal information